3 ) provides estimates of butyrylcholinesterase (BuChE) hydrolysis rates in vivo, not BuChE concentration. This method is not merely measuring the distribution of the radiotracer from a static image, but rather is based on the temporal kinetics of the radiotracer in vivo. The limited resolution of PET (10mm in this study) is insufficient to determine the histological location of [ 11 C]BMP cleavage. However, the PET measure is sensitive to BuChE hydrolysis of [ 11 C]BMP wherever it does occur within the field of view, even when each of these multiple sites (synapses, glia) is smaller than the resolution of the imaging system. Other information is needed to inform the histological location of hydrolysis.
For example, hydrolysis of acetylcholine is known to occur predominantly within cholinergic synapses by outwardly facing, membrane-anchored AChE and BuChE. 4 These are the critical sites where acetylcholine is concentrated and to which inhibition therapy is targeted. We have shown that PET methods quantify AChE or BuChE activities within tissue distributions that are accessible to systemically administered cholinesterase inhibitors and that match regional distributions of AChE 5 and BuChE. 3 Consequently, PET-measured AChE activity estimates activity in cholinergic terminals, where AChE is known to be concentrated primarily. The distribution of BuChE activity is known to be much more uniform, but does include the cholinergic synapses.
Unlike tissue homogenate assays of postmortem AD brain, our in vivo PET method could have been insensitive to substantial increases in sparse, but highly concentrated, dead foci of plaque BuChE that were poorly perfused and distant from cholinergic terminals. However, our in vivo method should have detected in living AD brain any substantial increase in BuChE activity that could have been associated with cholinergic synapses, and it did not.
